期刊文献+

高效液相色谱-质谱联用测定人血清地红霉胺浓度及其药动学研究 被引量:7

HPLC-MS Methods for the Determination of Erythromycylamine in Human Serum and the Pharmacokinetic Study
下载PDF
导出
摘要 进行高效液相色谱 -质谱联用测定人血清中地红霉胺浓度的方法学及其药动学研究。血清样品经0 1mol·L-1氢氧化钠溶液 0 .1ml碱化 ,乙酸乙酯提取 ,采用HypersilODS2色谱柱 ;乙腈∶甲醇∶水 (6 2∶30∶8,V V V)流动相 ;流速为 1.0ml·min-1。质谱条件为AP -ESI离子源 ,正离子模式 ,电喷雾电压 35psig ,干燥气 (N2 )流速 10.0L·min-1,干燥气温度 32 0℃ ,毛细管电压 4 0 0 0V ,碎片电压 170V ,选择性监测质荷比 (M Z)为 735.5的分子离子峰 (M +H)。结果 :在 5.0~ 12 0 0 . 0ng·ml-1范围内地红霉胺血清浓度呈线性关系 ,方法回收率大于 90 %。试验制剂地红霉素肠溶胶囊相对生物利用度F为 97.0 3%± 9.98%。高效液相色谱 -质谱联用测定人血清中地红霉胺浓度 ,灵敏、准确 。 A HPLC-MS method was established to determine the concentration of erythromycylamine in human serum. A Hypersil ODS2 column was used with acetonitrile-methanol-water (62∶30∶8). The flow rate was 1 0ml·min -1 . AP-ESI and M/Z of 735 were selected to quantify erythromycylamine. The linear range was 5~1200ng·ml -1 and the determination limit was 0 5ng·ml -1 .The method was sensitive, fast and accurate, it could be used in the monitoring of therapeutic drugs and human pharmocokinetic study of dirithromycin.
出处 《中国药事》 CAS 2005年第3期175-177,共3页 Chinese Pharmaceutical Affairs
关键词 地红霉素 地红霉胺 药动学 生物利用度 高效液相色谱-质谱法 HPLC-MS pharmacokinetic study dirithromycin erythromycylamine
  • 相关文献

参考文献6

  • 1Mazzei T, Surrenti C, Novelli A, et al. Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis [ J ].Antimicrob Agents Chemother, 1999, 43 (7): 1556.
  • 2Sides. G- D, Cermele B - J, Black H - R, et al.Pharmacokinetics of dirithromycin [ J ] . Antimicrob - chemother,1993, 31supplc: 65.
  • 3Leroyer C, Muller - Serieys C, Quiot J, et al. Dirithromyc in concentrations in bronchial mucosa and secretions [J].Respiration, 1998, 65 (5): 381.
  • 4Matera MG, tufano M.A, Polverino M, et al. Pulmonary concentrations of dirithromyin and erythromycin during acute exacerbation of mild chromic obstructive pulmonary disease [J]Eur Respir, 1997, 10 (1): 98.
  • 5Geerdes Fenge H F, Goetschi B, Rau. M, a al. Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumlation in polymorphonuclear leukocytes and in saliva [J] .Eur J Clin Pharmacol, 1997, 53(2): 127.
  • 6LaBreque D, Johlin F, Janda R, et al. Pharmcokinetics of dirithromycin in patients with impaired hepatic function [ J ].Antimicrob Chemother, 1993, 32 (5): 741.

同被引文献107

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部